PGEN
Price:
$4.82
Market Cap:
$1.45B
Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms includes UltraVector, which leverages advanced DNA construction and computational modeling to engineer complex gene expression programs; mbIL15, a gene designed to enhance immune cell function; the non-viral Sleeping Beauty transposon/transposase system for genetic modification; and AttSite recombinases, tools for precise DNA recombination. Furthermore,...[Read more]
Industry
Biotechnology
IPO Date
2013-08-08
Stock Exchange
NASDAQ
Ticker
PGEN
According to Precigen, Inc.’s latest financial reports and current stock price. The company's current ROE is -1768.51%. This represents a change of 1.55% compared to the average of -107.17% of the last 4 quarters.
The mean historical ROE of Precigen, Inc. over the last ten years is -235.80%. The current -1768.51% ROE has changed 650.01% with respect to the historical average. Over the past ten years (40 quarters), PGEN's ROE was at its highest in in the March 2025 quarter at 385.16%. The ROE was at its lowest in in the September 2025 quarter at -349.54%.
Average
-235.80%
Median
-113.11%
Minimum
-1198.61%
Maximum
22.43%
Discovering the peaks and valleys of Precigen, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 540.12%
Maximum Annual ROE = 22.43%
Minimum Annual Increase = -460.86%
Minimum Annual ROE = -1198.61%
| Year | ROE | Change |
|---|---|---|
| 2025 | -1198.61% | 265.68% |
| 2024 | -327.77% | 304.99% |
| 2023 | -80.93% | -460.86% |
| 2022 | 22.43% | -126.12% |
| 2021 | -85.86% | -66.18% |
| 2020 | -253.85% | 6.75% |
| 2019 | -237.79% | 69.40% |
| 2018 | -140.37% | 540.12% |
| 2017 | -21.93% | -34.17% |
| 2016 | -33.31% | 173.62% |
The current ROE of Precigen, Inc. (PGEN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-535.77%
5-year avg
-334.15%
10-year avg
-235.80%
Precigen, Inc.’s ROE is greater than Tourmaline Bio, Inc. (-24.42%), greater than ORIC Pharmaceuticals, Inc. (-35.33%), greater than Wave Life Sciences Ltd. (-56.41%), greater than Terns Pharmaceuticals, Inc. (-20.02%), greater than Amylyx Pharmaceuticals, Inc. (-55.69%), greater than Immatics N.V. (-45.27%), greater than Enliven Therapeutics, Inc. (-21.04%), greater than Relay Therapeutics, Inc. (-43.94%), greater than Nektar Therapeutics (-87.00%), less than Dianthus Therapeutics, Inc. (-1.78%),
| Company | ROE | Market cap |
|---|---|---|
| -24.42% | $1.23B | |
| -35.33% | $878.86M | |
| -56.41% | $1.19B | |
| -20.02% | $4.77B | |
| -55.69% | $1.30B | |
| -45.27% | $1.31B | |
| -21.04% | $3.15B | |
| -43.94% | $2.78B | |
| -87.00% | $1.19B | |
| -1.78% | $3.44B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Precigen, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Precigen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Precigen, Inc.'s ROE?
How is the ROE calculated for Precigen, Inc. (PGEN)?
What is the highest ROE for Precigen, Inc. (PGEN)?
What is the 3-year average ROE for Precigen, Inc. (PGEN)?
What is the 5-year average ROE for Precigen, Inc. (PGEN)?
How does the current ROE for Precigen, Inc. (PGEN) compare to its historical average?